What are the treatment options for macules and patches on the skin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Macules and Patches

For macules and patches covering less than 10% body surface area (BSA), initiate topical corticosteroids with oral antihistamines as first-line therapy, reserving systemic treatment for more extensive involvement. 1

Initial Assessment and Grading

The treatment approach depends critically on the extent of BSA involvement and associated symptoms:

  • Grade 1 (<10% BSA): Macules/patches with or without symptoms like pruritus, burning, or tightness 1
  • Grade 2 (10-30% BSA): Similar presentation but limiting instrumental activities of daily living 1
  • Grade 3 (>30% BSA): Limiting self-care activities of daily living 1

Treatment Algorithm by Grade

Grade 1 Management (<10% BSA)

Topical corticosteroids are the cornerstone of treatment:

  • For body lesions: Class I topical corticosteroids (clobetasol propionate, halobetasol propionate, or betamethasone dipropionate cream/ointment) 1
  • For facial lesions: Class V/VI corticosteroids (aclometasone, desonide, or hydrocortisone 2.5% cream) to minimize side effects 1
  • FDA-approved hydrocortisone: Apply to affected areas not more than 3-4 times daily 2

Oral antihistamines for symptomatic relief:

  • Non-sedating options: Cetirizine or loratadine 10 mg daily 1
  • Sedating option (especially for nighttime pruritus): Hydroxyzine 10-25 mg four times daily or at bedtime 1

Continue treatment without interruption at this grade 1

Grade 2 Management (10-30% BSA)

  • Continue the same topical and oral regimen as Grade 1 1
  • Obtain non-urgent dermatology referral for specialist evaluation 1
  • Do not interrupt ongoing therapy unless specifically directed 1

Grade 3 Management (>30% BSA)

This requires immediate escalation:

  • Hold any ongoing immunotherapy if applicable 1
  • Obtain same-day dermatology consultation 1
  • Rule out systemic involvement: Order CBC with differential and comprehensive metabolic panel 1

Systemic corticosteroids become necessary:

  • Prednisone 0.5-1 mg/kg/day (or equivalent methylprednisolone dose) 1
  • Continue until rash resolves to Grade 1 or less 1
  • Then initiate 4-6 week steroid taper 1

Maintain oral antihistamines as above 1

Special Considerations for Pruritus Management

When pruritus is the predominant symptom:

Mild/Localized Pruritus

  • Emollients: Use cream or ointment-based, fragrance-free products 1
  • Topical corticosteroids: Same regimen as above (Class I for body, Class V/VI for face) 1
  • Oral antihistamines: As previously described 1

Moderate Pruritus (Grade 2)

  • Dermatology referral indicated 1
  • Escalate to oral corticosteroids: Prednisone 0.5-1 mg/kg/day tapered over 2 weeks 1

Severe Pruritus (Grade 3)

  • Add GABA agonists: Pregabalin or gabapentin 100-300 mg three times daily 1
  • Oral corticosteroids: Prednisone 0.5-1 mg/kg/day tapered over 2 weeks 1
  • Dermatology referral mandatory 1

Supportive Skin Care

For congenital or chronic macules/patches:

  • Bland emollients: Thick creams or ointments with minimal fragrances or preservatives for chronic management 1
  • Bathing: Use water alone or nonsoap cleansers 2-3 times weekly, followed by emollient application 1
  • For eczematous changes: Add low- to mid-potency topical corticosteroids twice daily as needed for acute flares 1

Critical Pitfalls to Avoid

  • Never use topical corticosteroids as monotherapy for fungal infections, as they can worsen the condition 3
  • Do not delay dermatology consultation when BSA exceeds 30% or symptoms are severe 1
  • Avoid premature discontinuation of treatment in Grade 1-2 cases 1
  • Add PCP prophylaxis if immunosuppression exceeding 3 weeks is expected (>30 mg prednisone equivalent/day) 1
  • Start proton pump inhibitor for GI prophylaxis when systemic corticosteroids are initiated 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.